Diclofenac sodium - Transdermal Delivery Solutions

Drug Profile

Diclofenac sodium - Transdermal Delivery Solutions

Alternative Names: Diclofenac sodium spray - Transdermal Delivery Solutions; Disclofenac sodium TDS®

Latest Information Update: 28 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Transdermal Delivery Solutions Corp
  • Developer St. Bartholomews Hospital; Transdermal Delivery Solutions Corp
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for preclinical development in Pain in USA (Transdermal, Spray)
  • 27 May 2016 Diclofenac transdermal is still in non-clinical development for Pain (Company website - May 2016)
  • 09 May 2002 Preclinical trials in Pain in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top